Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
8
|
| pubmed:dateCreated |
1998-8-6
|
| pubmed:abstractText |
5-Substituted 6-azauracils were alkylated with (2-acetoxyethoxy)methly bromide to give protected acyclic nucleosides which were protected to afford acyclonucleosides of 5-substituted 6-azauracils. Their structures have been established by the UV and 1H-NMR spectra and by elemental analysis.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Aug
|
| pubmed:issn |
0732-8311
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
17
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1319-24
|
| pubmed:dateRevised |
2000-12-18
|
| pubmed:meshHeading | |
| pubmed:year |
1998
|
| pubmed:articleTitle |
As-triazine derivatives with potential therapeutic action. XXVI. Syntheses of 5-substituted-6-azauracil acyclonucleosides.
|
| pubmed:affiliation |
Chemical Pharmaceutical Research Institute, Bucharest, Romania.
|
| pubmed:publicationType |
Journal Article
|